Lisa Rojkjaer

Insider Reports History

Entity
Individual
Location
C/O Viracta Therapeutics, Inc., 2533 South Coast Hwy., Ste. 210, Cardiff, CA
Signature
/s/ Raymond Furey (Attorney-in-Fact)
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lisa Rojkjaer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Viracta Therapeutics, Inc. Chief Medical Officer Restricted Stock Units 37.1K $53.9K $1.45 Feb 25, 2023 Direct
Viracta Therapeutics, Inc. Chief Medical Officer Common Stock 48.1K $23.7K $0.49 Feb 27, 2023 Direct
RIGEL PHARMACEUTICALS INC EVP, Chief Medical Officer Employee Stock Option (right to buy) 188K Mar 27, 2024 Direct
Viracta Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 150K Mar 16, 2023 Direct

Insider Reports Filed by Lisa Rojkjaer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RIGL RIGEL PHARMACEUTICALS INC Mar 27, 2024 1 $0 4 Mar 29, 2024 EVP, Chief Medical Officer
RIGL RIGEL PHARMACEUTICALS INC Mar 27, 2024 0 $0 3 Mar 29, 2024 EVP, Chief Medical Officer
VIRX Viracta Therapeutics, Inc. Mar 16, 2023 1 $0 4 Mar 17, 2023 Chief Medical Officer
VIRX Viracta Therapeutics, Inc. Feb 25, 2023 3 -$3.62K 4 Feb 28, 2023 Chief Medical Officer
VIRX Viracta Therapeutics, Inc. Nov 25, 2022 3 -$5.75K 4 Nov 29, 2022 Chief Medical Officer
VIRX Viracta Therapeutics, Inc. Aug 25, 2022 3 -$8.79K 4 Aug 29, 2022 Chief Medical Officer
VIRX Viracta Therapeutics, Inc. May 25, 2022 3 -$4.09K 4 May 27, 2022 Chief Medical Officer
VIRX Viracta Therapeutics, Inc. Mar 17, 2022 1 $0 4 Mar 18, 2022 Chief Medical Officer
VIRX Viracta Therapeutics, Inc. Feb 25, 2022 3 -$6.66K 4 Mar 1, 2022 Chief Medical Officer
VIRX Viracta Therapeutics, Inc. Nov 25, 2021 4 -$21.8K 4 Nov 29, 2021 Chief Medical Officer
VIRX Viracta Therapeutics, Inc. May 11, 2021 4 $48.6K 4 May 13, 2021 Chief Medical Officer